Genome&Company Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genome&Company

Watchlist Manager

Watchlist

Price: 4 230 KRW -8.44% Market Closed

Market Cap: ₩191.4B

G	Genome&Company KOSDAQ:314130	KR
S	Southern Trust Securities Holding Corp OTC:SOHL	US
F	Forward Graphic Enterprise Co Ltd TPEX:8906	TW
P	Pattern Group Inc NASDAQ:PTRN	US
L	LabTurbo Biotech Corp TPEX:7725	TW
H	Hokuriku Gas Co Ltd TSE:9537	JP
	Enernorth Industries Inc OTC:ENYNF	CA
S	Shah Metacorp Ltd BSE:533275	IN
K	Kuang Hong Arts Management Inc TPEX:6596	TW
F	Focus Lightings Tech Co Ltd SZSE:300708	CN
	Fluidra SA OTC:FLUIF	ES
V	Vine Hill Capital Investment Corp NASDAQ:VCIC	US

Profitability Summary

Genome&Company's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

54%

Sustainable 3Y Average Gross Margin

48%

Gross Margin is Increasing

33% > 54%

Negative Operating Margin

-119%

Negative 3Y Average Operating Margin

-192%

Operating Margin is Increasing

-356% > -119%

Negative Net Margin

-24%

Negative 3Y Average Net Margin

-145%

Net Margin is Increasing

-285% > -24%

Negative Free Cash Flow Margin

-82%

Negative 3Y Average Free Cash Flow Margin

-139%

Free Cash Flow Margin is Increasing

-279% > -82%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-47%

ROIC is Increasing

-74% > -26%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.